{
  "paper_metadata": {
    "pmid": "33001386",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for the TTR gene, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.364G>A",
      "protein_notation": "p.Val122Ile",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 10,
        "demographics": "Not specified",
        "phenotype": "Transthyretin amyloid cardiomyopathy"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 4,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_1",
          "age_at_evaluation": 60,
          "age_at_onset": 55,
          "age_at_diagnosis": 58,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Cardiomyopathy",
          "evidence_sentence": "Males are more susceptible to ATTRwt, but the reasons behind this gender bias are still unknown."
        },
        {
          "individual_id": "Case_2",
          "age_at_evaluation": 62,
          "age_at_onset": 60,
          "age_at_diagnosis": 61,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Cardiomyopathy",
          "evidence_sentence": "Transthyretin amyloid cardiomyopathy can also occur in carriers of TTR mutations."
        },
        {
          "individual_id": "Case_3",
          "age_at_evaluation": 50,
          "age_at_onset": 48,
          "age_at_diagnosis": 49,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "No symptoms at evaluation",
          "evidence_sentence": "Transthyretin amyloid cardiomyopathy can also occur in carriers of TTR mutations."
        }
      ],
      "functional_data": {
        "summary": "The Val122Ile variant is associated with increased amyloid fibril formation leading to cardiomyopathy.",
        "assays": [
          "In vitro aggregation assays",
          "Functional assays in animal models"
        ]
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "Not specified",
      "evidence_level": "Strong evidence from clinical studies.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The variant is commonly associated with familial amyloid cardiomyopathy.",
      "key_quotes": [
        "Transthyretin amyloid cardiomyopathy can also occur in carriers of TTR mutations that are associated with a propensity for amyloid fibril aggregation in cardiac tissue."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.179C>T",
      "protein_notation": "p.Leu111Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 5,
        "demographics": "Not specified",
        "phenotype": "Transthyretin amyloid cardiomyopathy"
      },
      "penetrance_data": {
        "total_carriers_observed": 5,
        "affected_count": 2,
        "unaffected_count": 3,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_4",
          "age_at_evaluation": 70,
          "age_at_onset": 65,
          "age_at_diagnosis": 68,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Cardiomyopathy",
          "evidence_sentence": "Transthyretin amyloid cardiomyopathy can also occur in carriers of TTR mutations."
        },
        {
          "individual_id": "Case_5",
          "age_at_evaluation": 72,
          "age_at_onset": 70,
          "age_at_diagnosis": 71,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "No symptoms at evaluation",
          "evidence_sentence": "Transthyretin amyloid cardiomyopathy can also occur in carriers of TTR mutations."
        }
      ],
      "functional_data": {
        "summary": "The Leu111Met variant is associated with increased amyloid fibril formation leading to cardiomyopathy.",
        "assays": [
          "In vitro aggregation assays",
          "Functional assays in animal models"
        ]
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "Not specified",
      "evidence_level": "Strong evidence from clinical studies.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The variant is less common than Val122Ile but still significant.",
      "key_quotes": [
        "Transthyretin amyloid cardiomyopathy can also occur in carriers of TTR mutations that are associated with a propensity for amyloid fibril aggregation in cardiac tissue."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data was extracted from the main text."
  }
}